Menu Close
< Banner Randomizer >
< === Background-color: Start (#00518b) === >

At Lazarex Cancer Foundation we improve patient access to cancer clinical trials

< === Background-color: End === >
< News Brief >

Lazarex Care

The Lazarex Care program focuses on improving the outcome of cancer care for advanced stage cancer patients, and the medically underserved, by identifying FDA clinical trial options, providing assistance with out of pocket costs for clinical trial participation and a travel companion, and facilitating community outreach and engagement.
FIND OUT MORE

iMPACT

The goal of IMPACT is to generate a sustainable proof of concept action plan to transform the status quo of clinical trial recruitment, enrollment, retention, minority participation, completion, and translational science – providing equitable and timely access to cancer discovery for all patients.
FIND OUT MORE

Community iMPACT

Working with Drexel University School of Public Health in Philadelphia, Community IMPACT is a (pilot) community outreach and engagement public health initiative in the poorest neighborhoods of Philadelphia. The aim is to build a replicable program to improve cancer and overall health outcomes, transforming the way we think about cancer prevention and the actions we implement to reduce cancer burden.
FIND OUT MORE
< News Brief >

Charmaine Sarpong

Charmaine Sarpong is devoted to helping others. But when she was diagnosed with breast cancer in 2006, the tables were turned. She would now be the one asking for help.
READ MORE

Disrupting the System II

June 2019 we hosted some of the biggest disruptors and innovators in oncology, patient advocacy and public policy to discuss making cancer research more accessible to ALL patients. Watch the video from this very important meeting.
WATCH NOW

Community IMPACT Set to Launch

Earlier this month, Dornsife met with key players to discuss the latest IMPACT program. Nineteen people crowded into a meeting room at the Dornsife Center for Neighborhood Partnerships, a community resource center on Spring Garden Street. They included Penn oncologists, professors from Drexel’s Dornsife School of Public Health, and executives from Merck, a funder of the year-old, $3.5 million initiative.
READ THE ARTICLE